Susceptibility of organisms in the Mycobacterium fortuitum complex to antituberculous and other antimicrobial agents. 1977

W E Sanders, and E C Hartwig, and N J Schneider, and R Cacciatore, and H Valdez

Of 21 antimicrobial agents tested in vitro, amikacin was the most predictably active against clinical isolates belonging to the Mycobacterium fortuitum complex; however, only 50% of strains studied were susceptible to clinically attainable concentrations of the drug.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009161 Mycobacterium A genus of gram-positive, aerobic bacteria. Most species are free-living in soil and water, but the major habitat for some is the diseased tissue of warm-blooded hosts. Mycobacteria
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular

Related Publications

W E Sanders, and E C Hartwig, and N J Schneider, and R Cacciatore, and H Valdez
January 1983, Annales de microbiologie,
W E Sanders, and E C Hartwig, and N J Schneider, and R Cacciatore, and H Valdez
June 1979, Antimicrobial agents and chemotherapy,
W E Sanders, and E C Hartwig, and N J Schneider, and R Cacciatore, and H Valdez
February 2019, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy,
W E Sanders, and E C Hartwig, and N J Schneider, and R Cacciatore, and H Valdez
December 1995, Journal of chemotherapy (Florence, Italy),
W E Sanders, and E C Hartwig, and N J Schneider, and R Cacciatore, and H Valdez
October 1984, European journal of clinical microbiology,
W E Sanders, and E C Hartwig, and N J Schneider, and R Cacciatore, and H Valdez
December 1985, Antimicrobial agents and chemotherapy,
W E Sanders, and E C Hartwig, and N J Schneider, and R Cacciatore, and H Valdez
June 1985, Hiroshima journal of medical sciences,
W E Sanders, and E C Hartwig, and N J Schneider, and R Cacciatore, and H Valdez
June 1983, Annals of internal medicine,
W E Sanders, and E C Hartwig, and N J Schneider, and R Cacciatore, and H Valdez
November 1979, Antimicrobial agents and chemotherapy,
W E Sanders, and E C Hartwig, and N J Schneider, and R Cacciatore, and H Valdez
June 1990, The Journal of dermatology,
Copied contents to your clipboard!